America's Health Insurance Plans INC (Ahip)

Based in DC

🤖

AI Overview

With $96.4M in lobbying spend across 34 quarterly filings, America's Health Insurance Plans INC (Ahip) is one of the biggest lobbying spenders in Washington. They deploy 39 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$96.4M
Total Spend
8
Years Active
1
Firms Hired
39
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$9.7M
2019$9.5M
2020$10.5M
2021$11.3M
2022$13.3M
2023$13.1M
2024$11.8M
2025$17.2M

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Insurance, Taxation, Pharmacy

  • H.R. 1215, Protecting Access to Care Act (King) - medical liability reform
  • H.R. 1313, Preserving Employee Wellness Programs Act (Foxx) - employee wellness programs
  • S. 1625, FY 2018 Consolidated Appr
  • S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act (Capito) -PDP/MA-PD payments on clean claims from pharmacies
  • S. 428, ACE Kids Act (Grassley) - coordinated care for childre
  • Bipartisan Health Care Stabilization Act (Alexander-Murray) - funding for cost sharing reduction benefits, stabilization of individual market
  • Bipartisan Health Care Stabilization Act; updated version
  • S. 28, Health Savings Account Expansion Act (Flake) - HSA improvements
  • S. 85, Restoring Access to Medications Act (Roberts) - paying for OTC products with HSA funds
  • S. 403, Health Savings Act (Hatch)
  • S. 297, Increasing Competition in Pharmaceuticals Act (Collins-McCaskill) - prescription drug costs
  • S. 974, CREATES Act (Leahy-Grassley) - access to generic drugs and biosimilars
  • S. 1115, Making Pha

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.